Mark Altmeyer
President and Chief Executive Officer
Otsuka America Pharmaceutical, Inc.

Linda Bowers
VP Life Sciences Product Marketing
IntraLinks

Sean Brynjelsen
Vice President, Business Development and R&D
Akorn, Inc.

Carol Cruickshank
Vice President and Partner
A.T. Kearney

Matt Cushing
Partner
Bingham McCutchen

David H. Donabedian, PhD, MBA
Vice President, Global New Deal Strategy & Development
US CEEDD, GSK

Dimitri Drone
Partner
PwC

Chris Garabedian
President & CEO, AVI BioPharma and
Former Vice President, Corporate Strategy, Celgene

Adam Golden
Partner
Kaye Scholer

Keith M. Gottesdiener, M.D.
Vice President, Development
Merck & Co., Inc.

Milton Grannatt
Vice President & Head, Negotiations, Respiratory & New Growth Opportunities Global Business Development & Licensing
Novartis Pharmaceuticals Corporation

William Hoffman
Partner
Kaye Scholer LLP

Sharon Kochan
Executive Vice President, U.S. Generics
Perrigo Company

Jeff Levy
Director, Business Development
RR Donnelley

Michael Mentesana
US Pharmaceutical and Life Sciences R&D Advisory Services Leader
PwC

Polly Murphy
VP, R&D Business Development
Pfizer Inc.

Adelene Q. Perkins
President and Chief Executive Officer
Infinity Pharmaceuticals, Inc.

Marla S. Persky
Senior Vice President, General Counsel and Secretary
Boehringer Ingelheim USA Corporation

Barry Ticho, M.D., Ph.D.
Vice President, R&D
Biogen Idec

Pol Vandenbroucke
Vice President, Clinical Development, Emerging Markets Business Unit
Pfizer

Greg Wiederrecht, PhD, CLP
Vice President & Head, External Scientific Affairs Worldwide Licensing & External Research
Merck & Co., Inc.

Michael Wise
Partner
A.T. Kearney

Brett Zbar
Partner
Aisling Capital